What Is the Key to Aspirin's Benefit in CRC?

Why does aspirin increase survival only in some colon cancer patients? Dr. David Kerr reports on a study suggesting a PIK3CA mutation may be a predictive marker for use of aspirin as adjuvant therapy.

Source: Medscape Pathology and Laboratory Medicine Podcast - March 20, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts